← Back to Search

Text Messaging Intervention for Sedentary Lifestyle

N/A
Recruiting
Led By Karen Basen-Engquist, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years old or older
Be older than 18 years old
Must not have
Unable to walk without ambulatory assistance device (i.e. cane or walker) or due to underlying medical condition
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if a text messaging program can reduce sedentary behavior.

Who is the study for?
This trial is for adults over 18 who own a smartphone, can use WiFi or mobile data, have an email address (or are willing to create one), can read and understand English, consent to participate, are open to receiving texts and completing questionnaires on their phone. It's not for those who don't want their activity tracked or need walking aids due to medical conditions.
What is being tested?
The TEXT2MOVE study is testing whether an 8-week program that sends health-related text messages can help people sit less and be more active. Participants will receive these texts on their phones and may also use a FitBit device.
What are the potential side effects?
There aren't any direct medical side effects from participating in this study since it involves lifestyle changes rather than medication. However, increasing physical activity suddenly could potentially cause muscle soreness or strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I need a device like a cane or walker to walk due to a health condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Fit Bit (Study Groups)Experimental Treatment1 Intervention
Participants wear a Fitbit every day for 8 weeks to record the number of steps you take
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FitBit
2017
N/A
~480

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,068 Previous Clinical Trials
1,802,479 Total Patients Enrolled
Karen Basen-Engquist, MDPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
35 Total Patients Enrolled

Media Library

Mobile Phone Text-based Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05217108 — N/A
Healthy Lifestyle Research Study Groups: Fit Bit (Study Groups)
Healthy Lifestyle Clinical Trial 2023: Mobile Phone Text-based Intervention Highlights & Side Effects. Trial Name: NCT05217108 — N/A
Mobile Phone Text-based Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05217108 — N/A
~81 spots leftby Oct 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top